Two modalities are better than one: PET/CT IDs distant malignancies

October 18, 2012

Whole-body PET/CT has demonstrated excellent diagnostic performance for the detection of distant malignancies, according to a meta-analysis of medical literature published online ahead of print in the Journal of Nuclear Medicine .

The hybrid imaging modality was shown to be particularly effective at detecting distant malignancies in patients with head and neck cancer, breast cancer and lung cancer, according to Guozeng Xu, MD, of the First Affiliated Hospital of Guangxi Medical University, Nanning, China, and colleagues.